8/11/25: Looking at the BC 007 and rapamycin Long COVID and ME clinical trials
Update: 2025-08-12
Description
In this episode of Still Here: A two-way between Felicity Nelson and Betsy Ladyzhets comparing and contrasting the BC 007 and rapamycin Long COVID and ME clinical trial designs.
The transcript for this episode can be found on our website, or jump to a specific part of the podcast below:
(00:01:15 ) 2-way: Long COVID clinical trial design, BC 007 and rapamycin
-
Mentioned in this episode (in order of appearance):
- The Sick Times: Clinical trials are testing cancer drug rapamycin for Long COVID and ME
- The Sick Times: Berlin Cures’ failed Long COVID clinical trial yields lessons on study design
- Research Square: Simmaron preprint on low-dose rapamycin clinical trial
- medRxiv: Erlangan preprint on BC 007 clinical trial
- The Sick Times: How volunteering to be a lab rat paid off
Additional audio in this episode:
- Rude Mechanical Orchestra: Which Side Are You On? (orig. Florence Reece)
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
